Impact of an integrated classifier using biomarkers, clinical and imaging factors on clinical decisions making for lung nodules.

In patients with lung nodules with a pCA ≤50%, use of the integrated classifier was associated with fewer invasive procedures and clinic visits without misclassifying patients with likely benign lung nodules results at 1-year follow-up.